666

ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD

No trades
See on Supercharts
Market capitalization
‪3.01 B‬CNY
‪121.25 M‬CNY
‪1.35 B‬CNY
‪76.85 M‬
Beta (1Y)
1.39

About ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD

CEO
Cheng Chi
Headquarters
Taizhou
Website
Employees (FY)
‪1.58 K‬
Founded
1992
FIGI
BBG00PGD8PW9
Zhejiang East Asia Pharmaceutical Co., Ltd. engages in the manufacture and distribution of active pharmaceutical ingredients (API), tablets, granules and capsules. The company was founded in 1992 and is headquartered in Taizhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 605177 is 26.51 CNY — it has increased by 0.53% in the past 24 hours. Watch ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD stocks are traded under the ticker 605177.
605177 stock is 6.44% volatile and has beta coefficient of 1.39. Track ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD stock price on the chart and check out the list of the most volatile stocks — is ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD there?
Yes, you can track ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD financials in yearly and quarterly reports right on TradingView.
605177 stock has risen by 0.91% compared to the previous week, the month change is a 30.40% rise, over the last year ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD has showed a 8.87% increase.
605177 net income for the last quarter is ‪35.69 M‬ CNY, while the quarter before that showed ‪30.95 M‬ CNY of net income which accounts for 15.30% change. Track more ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD financial stats to get the full picture.
Today ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD has the market capitalization of ‪2.98 B‬, it has increased by 7.94% over the last week.
Yes, 605177 dividends are paid annually. The last dividend per share was 0.29 CNY. As of today, Dividend Yield (TTM)% is 1.09%. Tracking ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD dividends might help you take more informed decisions.
ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD dividend yield was 1.25% in 2023, and payout ratio reached 30.64%. The year before the numbers were 1.45% and 31.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 605177 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
605177 reached its all-time high on Nov 30, 2020 with the price of 57.25 CNY, and its all-time low was 14.96 CNY and was reached on Feb 6, 2024. View more price dynamics on 605177 chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪1.58 K‬ employees. See our rating of the largest employees — is ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD stock shows the strong buy signal. See more of ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD EBITDA is ‪221.53 M‬ CNY, and current EBITDA margin is 16.77%. See more stats in ZHEJIANG EAST-ASIA PHARMACEUTICAL CO., LTD financial statements.